CLRB Cellectar Biosciences, Inc.

Fundamentals / CIK 0001279704 / USD

Cellectar Biosciences, Inc. reported $29.74M in total assets and a net loss of $25.85M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CLRB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$41.68MFY 2016 Net Income: -$6.18M2016FY 2017 Net Income: -$13.56M2017FY 2018 Net Income: -$13.24M2018FY 2019 Net Income: -$14.09M2019FY 2020 Net Income: -$15.09M2020FY 2021 Net Income: -$24.12M2021FY 2022 Net Income: -$28.60M2022FY 2023 Net Income: -$42.77M2023FY 2024 Net Income: -$44.58M2024FY 2025 Net Income: -$21.79M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $11.50M $26.14M $27.27M $19.22M $17.59M $10.14M $9.00M $6.84M $9.47M $4.75M
Operating Income -$22.98M -$51.78M -$38.96M -$28.81M -$24.13M -$15.29M -$14.18M -$13.33M -$13.60M -$9.45M
EBITDA -$22.77M -$51.49M -$38.77M -$28.67M -$23.98M -$15.15M -$14.05M -$13.25M -$12.05M -$9.09M
Income Before Tax -$21.79M -$44.52M -$42.83M -$28.66M -$24.12M -- -- -- -- --
Income Tax Expense -- $66K -$60K -$60K -- -- $0 $0 $0 $0
Net Income -$21.79M -$44.58M -$42.77M -$28.60M -$24.12M -$15.09M -$14.09M -$13.24M -$13.56M -$6.18M
Basic EPS -$8.35 -$36.52 -$105.11 -$121.62 -$130.63 -$22.82 -$55.26 -$157.06 -$321.32 -$64.26
Diluted EPS -$8.35 -$41.89 -$105.11 -$121.62 -$130.63 -$55.26 -$55.26 -$157.06 -$321.32 -$64.26
Basic Shares Outstanding 2.6M 1.2M 407.0K 235.0K 184.9K 659.8K 255.6K 98.6K 46.7K 145.4K
Diluted Shares Outstanding 2.6M 1.2M 407.0K 235.0K 184.9K 659.8K 255.6K 98.6K 46.7K 145.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $5.44M $4.56M $3.01M $3.16M $2.52M $2.39M $3.43M $6.21M
Operating Income -$8.10M -$7.20M -$5.79M -$5.69M -$4.85M -$6.04M -$6.40M -$12.74M
EBITDA -- -- -- -$5.64M -$4.80M -$5.98M -$6.34M -$12.68M
Net Income -$7.97M -$6.93M -$5.65M -$5.30M -$4.44M -$5.45M -$6.60M -$2.36M
Basic EPS -$0.46 -$0.57 -$1.33 -- -$1.41 -$3.39 -$4.30 --
Diluted EPS -$0.46 -$0.57 -$1.33 -- -$1.41 -$3.39 -$4.30 --
Basic Shares Outstanding 17.5M 12.2M 4.2M -- 3.2M 1.6M 1.5M --
Diluted Shares Outstanding 17.5M 12.2M 4.2M -- 3.2M 1.6M 1.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $13.20M $23.29M $9.56M $19.87M $35.70M $57.17M $10.61M $13.26M $10.01M $11.44M
Cash & Short-Term Investments $13.20M $23.29M $9.56M $19.87M $35.70M $57.17M $10.61M $13.26M $10.01M $11.44M
Total Current Assets $14.04M $24.25M $10.45M $20.53M $36.57M $57.94M $11.39M $13.95M $10.47M $12.19M
Property, Plant & Equipment, Net $549K $757K $1.09M $419K $344K $356K $435K $543K $245K $1.44M
Goodwill -- -- -- -- -- -- $0 $0 $1.68M $1.68M
Long-Term Investments -- -- $24K $75K $75K $75K $75K $541K $466K --
Other Non-Current Assets $30K $30K $30K $6.2K $6.2K $6.2K $6.2K $18K $12K $12K
Total Non-Current Assets $940K $1.22M $1.62M $1.06M $630K $720K $865K $1.10M $2.40M $3.13M
Total Assets $14.98M $25.47M $12.08M $21.59M $37.20M $58.66M $12.25M $15.05M $12.87M $15.32M
Accounts Payable $1.44M $4.11M $5.62M $2.56M $1.42M $1.43M $1.28M $612K $933K --
Total Current Liabilities $4.75M $9.39M $25.36M $5.53M $3.99M $3.56M $2.77M $1.62M $2.11M $1.63M
Total Non-Current Liabilities $309K $410K $494K $553K $166K $302K $422K $171K $2.2K $152K
Total Liabilities $5.06M $9.80M $25.85M $6.08M $4.16M $3.86M $3.19M $1.79M $2.12M $1.78M
Total Debt (incl. Leases) $410K $494K $553K $604K $302K $422K $528K $2.2K -- --
Common Stock $42 $15 $207 $94 $61 $454 $94 $47 $16 $104
Retained Earnings -$269.1M -$247.3M -$202.8M -$179.5M -$150.9M -$126.8M -$111.7M -$97.59M -$84.35M -$70.79M
Total Stockholders' Equity $8.54M $14.29M -$15.16M $8.15M $33.05M $54.79M $9.06M $13.26M $10.75M $13.54M
Total Equity $8.54M $14.29M -$15.16M $8.15M $33.05M $54.79M $9.06M $13.26M $10.75M $13.54M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $24.58M $33.99M $8.35M $13.20M $12.55M $11.04M $13.91M $23.29M
Cash & Short-Term Investments $24.58M $33.99M $8.35M $13.20M $12.55M $11.04M $13.91M $23.29M
Total Current Assets $25.71M $34.88M $9.27M $14.04M $13.62M $12.62M $14.89M $24.25M
Property, Plant & Equipment, Net $269K $304K $340K $549K $595K $648K $701K $757K
Other Non-Current Assets $95K $24K $30K $30K $30K $30K $30K $30K
Total Non-Current Assets $4.03M $1.76M $1.85M $940K $1.01M $1.08M $1.15M $1.22M
Total Assets $29.74M $36.64M $11.12M $14.98M $14.63M $13.70M $16.04M $25.47M
Accounts Payable -- -- -- $1.44M -- -- -- $4.11M
Total Current Liabilities $5.80M $5.24M $4.87M $4.75M $4.91M $5.87M $6.02M $9.39M
Total Non-Current Liabilities $1.53M $1.53M $1.53M $309K $336K $361K $386K $410K
Total Liabilities $7.33M $6.77M $6.40M $5.06M $5.25M $6.23M $6.41M $9.80M
Total Debt (incl. Leases) $1.53M $1.53M $1.53M $410K $433K $454K $476K $494K
Common Stock $100 $83 $42 $42 $32 $18 $461 $15
Retained Earnings -$289.7M -$281.7M -$274.8M -$269.1M -$263.8M -$259.4M -$253.9M -$247.3M
Total Stockholders' Equity $22.42M $29.87M $3.34M $8.54M $8.00M $6.09M $8.25M $14.29M
Total Equity $22.42M $29.87M $3.34M $8.54M $8.00M $6.09M $8.25M $14.29M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$21.79M -$44.58M -$42.77M -$28.60M -$24.12M -$15.09M -$14.09M -$13.24M -$13.56M -$6.18M
Depreciation & Amortization $214K $292K $192K $148K $150K $141K $133K $82K $1.55M $357K
Stock-Based Compensation $2.26M $4.27M $2.41M $1.45M $1.12M $468K $867K $721K $759K $529K
Operating Cash Flow -$23.12M -$47.58M -$32.38M -$25.22M -$22.57M -$13.93M -$11.69M -$11.44M -$11.02M -$8.28M
Capital Expenditure -$5.9K -$104K -$864K -$226K -$141K -$62K -$25K -$385K -$347K -$72K
Free Cash Flow -$23.12M -$47.69M -$33.24M -$25.45M -$22.71M -$14.00M -$11.72M -$11.83M -$11.37M -$8.35M
Investing Cash Flow -$5.9K -$104K -$864K -$226K -$141K -$62K -$25K -$330K -$347K -$72K
Common Stock Issued -- -- -- $9.61M $35K $59.72M $9.02M $9.08M $4.91M $12.36M
Financing Cash Flow $13.03M $61.41M $22.94M $9.61M $1.25M $60.55M $9.02M $15.02M $9.93M $15.94M
Net Change in Cash -$10.09M $13.72M -$10.30M -$15.84M -$21.46M $46.55M -$2.70M $3.25M -$1.44M $7.59M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.97M -$6.93M -$5.65M -$5.30M -$4.44M -$5.45M -$6.60M -$2.36M
Depreciation & Amortization -- -- -- $49K $52K $56K $56K $69K
Stock-Based Compensation $518K $428K $452K $568K $568K $565K $563K $1.49M
Operating Cash Flow -$9.41M -$6.01M -$4.85M -$4.34M -$4.28M -$5.12M -$9.38M -$10.91M
Capital Expenditure $0 $0 -$3.4K -- -- -- -- -$61K
Free Cash Flow -$9.41M -$6.01M -$4.85M -- -- -- -- -$10.97M
Investing Cash Flow $0 $0 -$3.4K -- -- -- -- -$61K
Financing Cash Flow -- -- -- -- -- -- -- $0
Net Change in Cash -$9.41M $25.65M -$4.85M $642K $1.51M -$2.86M -$9.38M -$10.97M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -255.2% -311.9% -- -350.8% -73.0% -27.5% -155.6% -99.8% -126.1% -45.6%
Return on Assets (ROA) -145.5% -175.0% -354.2% -132.5% -64.8% -25.7% -115.0% -87.9% -105.4% -40.3%
Current Ratio 2.96x 2.58x 0.41x 3.71x 9.16x 16.26x 4.11x 8.60x 4.95x 7.47x
Quick Ratio 2.78x 2.48x 0.38x 3.59x 8.95x 16.04x 3.83x 8.17x 4.73x 7.01x
Debt to Equity 0.05x 0.03x -- 0.07x 0.01x 0.01x 0.06x 0.00x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -115.3% -74.7% -624.9% -255.2% -235.7% -477.8% -297.4% -311.9%
Return on Assets (ROA) -86.9% -60.9% -187.4% -145.5% -128.9% -212.3% -153.0% -175.0%
Current Ratio 4.44x 6.66x 1.90x 2.96x 2.77x 2.15x 2.47x 2.58x
Quick Ratio 4.24x 6.49x 1.71x 2.78x 2.56x 1.88x 2.31x 2.48x
Debt to Equity 0.07x 0.05x 0.46x 0.05x 0.05x 0.07x 0.06x 0.03x
Source: SEC EDGAR CompanyFacts (CIK 0001279704) · from December 31, 2002 Data through September 30, 2026 · synced Nov 21, 2026, 05:06 UTC · Open in terminal